Unum Therapeutics to raise about $104.4m

Cambridge, Massachusetts-based Unum Therapeutics Inc, a biopharmaceutical company focused on developing therapies for solid tumors, is expected to raise about $104.4 million in a private placement.

Cambridge, Massachusetts-based Unum Therapeutics Inc, a biopharmaceutical company focused on developing therapies for solid tumors, is expected to raise about $104.4 million in a private placement. Fairmount Funds Management LLC is the lead investor. Other investors include Venrock Healthcare Capital Partners, BVF Partners L.P., Atlas Venture, Acorn Bioventures, Perceptive Advisor’s LLC, RTW Investments, OrbiMed, Samsara BioCapital, Logos Capital, Ally Bridge Group and Commodore Capital.

Source: Press Release